Improve the management of lymphedema and related disorders in the United States while contributing to global international advancement.
This mission will be achieved by defining best practices of lymphedema management and developing a minimum data set to improve lymphedema outcomes. The ALFP will establish a leadership role in lymphedema risk reduction, treatment, education, health policy, and research. These outcomes will be achieved through a partnership among all lymphedema stakeholders, including patients, healthcare professionals, researchers, industry representatives, and third-party payers.
Jane Armer, PhD, RN, FAAN
Joseph Feldman, MD, CT-LANA
Janice Cormier, MD, MPH
Executive Committee (emeritus)